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ABSTRACT
The high peak power neodymium YAG laser and the HeNe laser aboard GAS-449
have demonstrated the survivability of the devices in the micro-gravity,
cosmic radiation, thermal, and shock environment of space. Some
pharmaceuticals and other materials flown in both the active and passive
status have demonstrated reduction in volume and unusual spectroscopic
changes. X-ray detectors have shown cosmic particle hits with accompanying
destruction at their interaction points. Some scattering in the plates is in
evidence. Some results of both active and passive experiments on board the
GAS-449 payload are evaluated.
INTRODUCTION
GAS Payload G-449 (Fig. l) was successfully flown aboard Columbia Mission
61-C between January 12, 1986 and January 18, 1986.
Payload GAS-449 operated as expected and was turned on during orbit #3, 3
hours and 43 minutes mission elapsed time and was turned off during orbit #8,
at lO hours and 48 minutes mission elapsed time. The timer on board GAS-449
operated for 30 minutes from startl.
The payload was under development for over 2 I/2 years and combined the
invited efforts of experimenters throughout the United States. The payload
was flown upon the maiden flight of the GAS bridge2. A total of 13 GAS
containers were flown upon the bridge.
The experiments were divided into four separate sections which were BMJ,
LEDAJO, CROLO, and BLOTY. The B_ experiment investigated the effects of
neodymium and helium-neon laser light upon desiccated human tissue undergoing
cosmic ray bombardment along with medications exposed to laser light and
cosmic radiation bombardment. LEDAJO investigated radiation effects and some
laser effects upon medications and medical/surgical materials and health care
products. CROLO was designed to investigate cosmic radiation effects upon
laser optical protective eyewear. BLOTY was designed to evaluate blood typing
in zero gravity.
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Six monthsafter the mission was flown there have been someresults which
are now ready for publication. Weexpect that at year's end there will be
additional material available for publication. Someof the results are as
fol lows:
The l megawattpeak power miniature Q-switched YAGlaser built and
supplied by Laser Photonics, Orlando, Florida (Fig. 2) flown on board the
payload operated as anticipated and pre-flight and post-flight testing
indicates the laser to be fully operational. There appears to be no damageor
side effects to the laser. The HeNelaser, supplied by GammexInc.,
Milwaukee, Wisconsin, in pre-flight and post-flight tests showedno
operational damageor side effects.
EXPERIMENT REPORTS
EXPERIMENT BMJ - PRELIMINARY REPORT
Benjamin Narodick, M.D., Investigator, Cancer Chemotherapy Drug Project
The experiment BMJ was conducted to determine the effect of cosmic
radiation, zero gravity and laser radiation on drugs, some of which are used
in cancer therapy.
Background
A. It has been widely reported that crystal formation in space (not
being subjected to gravity) results in structural arrangements
different from those in gravity 3. There are also indications that
changes in the molecular structure of solid substances can also occur
perhaps due to being subjected to cosmic radiation.
B. Cancer chemotherapy drugs vary in their ability to destroy cancer
cells and while they have proved useful as an adjunct to surgery and
X-ray radiation, mortality rate studies have been disappointing. It
is possible that changes in molecular structure might enhance their
effectiveness.
C. Certain drugs, such a porphyrins, are known to concentrate in tumor
tissue and acting as a photosensitizer, releases singlet oxygen when
exposed to laser radiation. This photo therapy effect is now limited
to superficial tissue. Space changes might enhance the sensitivity
of the various drugs to laser light so that deep seated cancers might
be effected by photo radiation.
Procedure
The most effective cancer chemotherapeutic drugs were studied for
inclusion in the experiment. All were crystalline and of sufficient potency
to be placed in a small glass vials and still be sufficient for study upon
return from space. The manufacturers of the drugs were contacted and approval
was obtained for these companies to conduct investigations and to report any
alteration that might have occurred.
Because of space limitations, the drugs were placed in three groups:
A. Nineteen vials subjected to cosmic radiation and weightlessness.
B. Eight vials subjected to cosmic radiation, weightlessness and YAG
laser irradiation.
C. Three vials subjected to cosmic radiation weightlessness and HeNe
laser radiation.
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Eleven different cancer chemotherapy drugs from the four major 
pharmaceutical companies and nine porphyrin compounds were d i s t r i b u t e d  i n  the 
three groups. Doubles account for  the number discrepancy. 
Results 
were immediately apparent. Although a l l  v ia l s  were completely f i l l e d  prior t o  
f l i g h t ,  i t  i s  t o  be noted tha t  two containers contained clumps of material, 
one approximately 20% of i t s  in i t i a l  volume ( F i g .  3). 
returned t o  the manufacturers for  complete analysis. Prel iminary reports have 
been requested from the pharmaceutical companies. 
received showing no apparent chemical changes b u t  animal studies have y e t  t o  
be completed. One investigator has suggested tha t  some unusual u l  t ra-violet  
responses have occurred and there have been other h i n t s  of changes i n  the 
effectiveness of some of the drugs.  I anticipate tha t  final reports will be 
available by January 1 , 1987. 
Upon opening the BMJ experimental compartment of GAS-449, some changes 
A l l  samples were 
One has already been 
Laser Carbon Experiment: Erich C. Muehlenbeck, M.D., Investigator 
Electron microscopy and chemical studies are  ongoing - reports due December 
1986. 
Tissue Experiment: Joseph H. Bellina, M.D. , Ph.D. 
Investigation i n  progress. Report i s  expected by the end of the year. 
Optical Wave Guide Experiment: 
Currently eval uati ng transmission of Nd YAG 1 aser wave1 eng ths  through the 
materials i n  the experiment. 
Stephen N .  Joffe,  M.D. 
F i g .  3 
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EXPERIMENT LEDAJO - PRELIMINARY REPORT
Leon Goldman, M.D.
Specimens were examined grossly under sterile techniques. One-half of the
specimens have been sent to manufacturers for detailed investigation.
Official report by research area is expected by the end of the year.
EXPERIMENT CROLO - PRELIMINARY REPORT
R. James Rockwell, Jr.
Effects Of Space Radiations On Laser Eye Protective Filters
Following the return of the filters, spectrographic analysis was performed
and all cases were shown to have what appeared to be the same spectrographic
characteristics on all filters as prior to flight. There appeared to be some
surface changes that would require electron microscope analysis. This is
being pursued at this time.
General conclusion: It appears that based upon the experiences from this
flight, eye projection would provide adequate protection for laser exposure
had they been required to be used.
EXPERIMENT BLOTY - PRELIMINARY REPORT
R. Tom Morehead, M.D., Thomas A. Olsen, MT (ASCP) SBB, Ellet H. Drake, M.D.
Erythrocyte Agglutination In Micro-Gravity
We tested the hypothesis that antibody mediated erythrocyte agglutination
would be retarded in near zero gravity by launching a self contained
experiment on board the Columbia space shuttle January 12, 1986. Experiment
tested Rh, ADO and Coombs sensitized human red blood cells against their
appropriate anti sera and diluentes. A self contained device was built which
mixed and pumped the reagents through tubing and collected the agglutinates on
filter paper after optimal mixing and delay. The device was flown aboard
GAS-449 in an insullated cannister which was carried on the bridge of the
payload bay of the Columbia. The experiment was initiated on the third orbit
about 3 hours and 43 minutes after launch. After conclusion of the
experiment, the agglutinates were held on filter paper.
Both the Rh and Rh control test systems failed because of crystallization
of the high protein antibody reagent. The remaining three systems functioned
as expected. After comparing these results to similar experiments adopted in
our lab under full gravity, we conclude that ADO and Coombs sensitized blood
grouping tests do occur under micro-gravity although the agglutinates formed
may be smaller and less discrete. We are exploring reasons for this
difference. To our knowledge, this is the first experiment that tests blood
agglutination in space.
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I f  . 
Investigation i n t o  the cosmic radiation effects  upon CR-39, Lexan and 
X-ray plates will be part  of a future paper. However, the X-ray plates (Kodak 
EP-21) have exposure and par t ic le  h i t  points. The CR-39 and Lexan are  under 
evaluation and because o f  their a t t i tude  relationship t o  each experiment, we 
do not expect resul ts  before the end of the year. The materials mentioned 
were flown as detectors to ascertain cosmic radiation h i t  points and were 
located a t  discrete positions i n  each cannister aboard the payload. 
OTHER PHENOMENON 
Additionally, there are pits (Fig.  4)  on the outside surface of the 
cannister containing the laser.  The cannister i s  made o f  303 stainless. 
source of these p i t s  is  undetermined. 
The 
F i g .  4 
CONCLUSION 
The performance of GAS-449 on board the Space S h u t t l e  Columbia Mission 
61-C performed i n  some instances as  expected and i n  many instances beyond our 
expectations, an example of which i s  the YAG laser. Continuing investigation 
into the experiments i s  expected to  yield additional positive results. Some 
data may remain unexplained due to  phenomenon not understood a t  the present. 
The systems which triggered the experiments functioned perfectly and the 
t iming  of the experiment was 30 minutes. 
of the investigators a t  the time of this w r i t i n g .  
experiments will continue and will  be the subject of a future paper. 
There have not been reports from a l l  
Investigation into the 
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